Solid Biosciences (SLDB) Current Leases (2018 - 2026)

Solid Biosciences has reported Current Leases for 9 years, with the latest figure at $2.2 million in Q1 2026.

• Quarterly Current Leases rose 17.13% year-over-year to $2.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.2 million (up 17.13% YoY) and the FY2025 annual result came in at $2.1 million, up 70.84% from the prior year.
• Current Leases grew to $2.2 million in Q1 2026 per SLDB's latest filing, from $2.1 million in the prior quarter.
• Over five years, Current Leases peaked at $2.2 million in Q1 2026 and troughed at $33000.0 in Q2 2022.
• A 5-year average of $1.2 million and a median of $1.1 million in 2024 frame the typical range for Current Leases.
• The sharpest annual moves came in 2022 and 2023: Current Leases slumped 97.8% in 2022, then soared 5515.15% in 2023.
• Over 5 years, Current Leases stood at $668000.0 in 2022, then soared by 177.69% to $1.9 million in 2023, then tumbled by 33.64% to $1.2 million in 2024, then surged by 70.84% to $2.1 million in 2025, then increased by 4.04% to $2.2 million in 2026.
• According to Business Quant data, Current Leases over the past three periods registered $2.2 million, $2.1 million, and $281000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.